Gene Therapy product-MCO-010 is named as a drug or biological intervention in 2 clinical trials in our USA trial register, none of which are currently recruiting. The lead sponsor is Nanoscope Therapeutics Inc.. Registered phase: Observational. Conditions studied include Retinitis Pigmentosa; Retinitis; Retinal Diseases.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT06048185 | Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study (ClinicalTrials.gov ↗) Stargardt Disease |
Observational | Active, closed |
| NCT06162585 | Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study (ClinicalTrials.gov ↗) Retinitis Pigmentosa, Retinitis, Retinal Diseases |
Observational | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Retinitis Pigmentosa | 1 |
| Retinitis | 1 |
| Retinal Diseases | 1 |
| Eye Diseases | 1 |
| Stargardt Disease | 1 |
| Lead sponsor | Trials |
|---|---|
| Nanoscope Therapeutics Inc. | 2 |
| Register | Gene Therapy product-MCO-010 trials |
|---|---|
| Clinical trials in USA | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Gene Therapy product-MCO-010 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Gene Therapy product-MCO-010 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.